Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Mumps virus vaccine, live, for subcutaneous use

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 90704 refers to the mumps virus vaccine, which is a live vaccine administered subcutaneously. Vaccines, unlike immune globulins that provide short-term, passive immunity, are designed to elicit an active immune response. This is achieved by introducing altered versions of specific viruses or bacteria into the body, prompting the immune system to produce its own antibodies. The immune system then retains a memory of these antibodies, allowing for a quicker and more effective response upon subsequent exposures to the same antigens. The mumps vaccine specifically contains an attenuated, or weakened, form of the mumps virus. This attenuation ensures that while the vaccine can stimulate the immune system to generate a protective response, it does not possess the virulence necessary to cause the disease itself. The administration of this vaccine is crucial in preventing mumps, a contagious viral infection that can lead to serious complications. The code 90704 is specifically designated for the mumps vaccine, distinguishing it from other related vaccines such as those for measles and rubella, which are reported under different codes. The live virus vaccines for measles, mumps, and rubella are all administered subcutaneously, ensuring effective delivery and immune response activation.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The mumps virus vaccine is indicated for the prevention of mumps, a viral infection that can lead to serious complications such as orchitis, oophoritis, and meningitis. Vaccination is particularly important for children, as they are at a higher risk of contracting the disease. The vaccine is also recommended for individuals who may be at increased risk due to exposure in communal settings, such as schools or daycare facilities.

  • Prevention of Mumps The primary indication for administering the mumps virus vaccine is to prevent the occurrence of mumps infection in individuals, particularly in children.
  • At-Risk Populations The vaccine is also indicated for individuals who are at higher risk of exposure to the mumps virus, such as those in close-contact environments.

2. Procedure

The administration of the mumps virus vaccine involves several key procedural steps to ensure safety and efficacy. First, the healthcare provider prepares the vaccine by checking the expiration date and ensuring that it has been stored correctly. The vaccine is typically supplied in a vial and must be reconstituted if it is in a lyophilized form. Once prepared, the provider selects an appropriate site for subcutaneous injection, usually the outer aspect of the upper arm or the thigh for infants. The injection site is cleaned with an antiseptic wipe to minimize the risk of infection. The provider then uses a sterile syringe and needle to administer the vaccine, injecting it into the subcutaneous tissue at a 45-degree angle. After the injection, the provider may apply gentle pressure to the site with a cotton ball or gauze to prevent bleeding. Finally, the provider documents the administration of the vaccine in the patient's medical record, including the date, site of injection, and any relevant lot numbers for tracking purposes.

  • Step 1: Vaccine Preparation The healthcare provider checks the expiration date and ensures proper storage of the vaccine before preparation.
  • Step 2: Site Selection An appropriate site for subcutaneous injection is selected, typically the outer aspect of the upper arm or thigh.
  • Step 3: Site Cleaning The injection site is cleaned with an antiseptic wipe to reduce the risk of infection.
  • Step 4: Vaccine Administration The vaccine is injected into the subcutaneous tissue at a 45-degree angle using a sterile syringe and needle.
  • Step 5: Post-Injection Care Gentle pressure is applied to the injection site with a cotton ball or gauze to prevent bleeding, followed by documentation of the procedure.

3. Post-Procedure

After the administration of the mumps virus vaccine, patients are typically monitored for a short period to observe for any immediate adverse reactions, such as allergic responses. It is common for patients to experience mild side effects, including soreness at the injection site, low-grade fever, or rash, which usually resolve on their own. Patients should be advised to report any unusual or severe reactions to their healthcare provider. Additionally, it is important to document the vaccination in the patient's medical record, including the date of administration and any relevant lot numbers for future reference. Follow-up appointments may be scheduled as part of routine immunization schedules to ensure that individuals receive all necessary vaccinations for comprehensive protection against mumps and other vaccine-preventable diseases.

Short Descr MUMPS VACCINE SC
Medium Descr MUMPS VIRUS VACCINE LIVE SUBCUTANEOUS
Long Descr Mumps virus vaccine, live, for subcutaneous use
Status Code Excluded from Physician Fee Schedule by Regulation
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE Not applicable/unspecified.
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
Date
Action
Notes
2016-01-01 Deleted Deleted
2011-01-01 Changed Short description changed.
2004-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"